Page 6 - OHKF_Biotech_EN

Executive summary Biotech is a broad-scoped discipline. As biomedicine has the In order to foster the above-mentioned ecosystem, it is incumbent
for the two cities to devise a comprehensive, concrete and long-
highest significance and the biggest potential for collaboration, it
forms the focus of the present study. Having taken into account
term plan. We make four recommendations (Recommendations
1–4) for the reference of the two governments to address existing
the respective strengths and development directions of the two
barriers that hamper collaboration. Moreover, the development of
cities, four major areas of collaboration centred on the Loop are
biotech in Hong Kong and Shenzhen is closely related to national
put forward (Table 1):
planning and policies. The Central Government’s support is
essential for addressing issues of a more marco or cross-border
Table 1 Four major areas of collaboration between nature. We thus put forward three recommendations
Hong Kong and Shenzhen
(Recommendations 5–7) for the reference of Central Ministries
Area of Overview of mode of collaboration and Departments.
collaboration
Coordinated in the Loop to achieve all- Recommendation 1 Establishing anchor
Drugs and stage and multifactored collaboration that institutions in the region to expedite development
vaccines encompasses drug development, of a biotech industrial cluster
production and product launch
Hong Kong and Shenzhen have yet to establish a world-renowned
With collaborative development in the
Loop, teams in Hong Kong and Shenzhen biotechnology industrial cluster. Meanwhile, Shanghai and Boston
Genetic testing will focus on different markets; market have adopted an “anchor institution” approach: major enterprises
and therapies access restrictions will be eased to allow or research institutes were introduced to create an environment
eligible enterprises in the Loop to enter the conducive to the development of local start-ups and industries.
Mainland market This in turn facilitates the formation of a world-class biotech
Advanced medical Corporates establish themselves in the industrial cluster.
devices Loop to leverage Hong Kong’s strengths in
medical research and clinical trials and Drawing on the above-mentioned approach, we recommend that
Application of AI to Shenzhen’s expertise in AI and mechanical a multipronged strategy be adopted to expedite the development
biotechnology manufacturing of the HK-SZ biotech industrial cluster in the Loop. In the short-
term, government departments and relevant organisations in the
two cities should proactively approach leading biotech enterprises.
Incentives like tax concessions, rental discounts and government-
guaranteed low-interest loans can be provided to attract

4